Feng Cheng

415 total citations
16 papers, 292 citations indexed

About

Feng Cheng is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Feng Cheng has authored 16 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Feng Cheng's work include HIV/AIDS Research and Interventions (8 papers), HIV, Drug Use, Sexual Risk (5 papers) and HIV Research and Treatment (3 papers). Feng Cheng is often cited by papers focused on HIV/AIDS Research and Interventions (8 papers), HIV, Drug Use, Sexual Risk (5 papers) and HIV Research and Treatment (3 papers). Feng Cheng collaborates with scholars based in China, Australia and United Kingdom. Feng Cheng's co-authors include Jun Jing, Lei Zhang, Shu Su, Christopher K. Fairley, Wubin Xie, Guanghua Lan, Mary Bachman DeSilva, Christopher Gill, Hongyan Lu and Jessica E. Haberer and has published in prestigious journals such as Scientific Reports, International Journal of Environmental Research and Public Health and BioMed Research International.

In The Last Decade

Feng Cheng

15 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Cheng China 9 134 132 86 46 41 16 292
Nicole C. McCann United States 10 120 0.9× 119 0.9× 93 1.1× 43 0.9× 29 0.7× 24 388
Hongxin Zhao China 12 134 1.0× 286 2.2× 86 1.0× 27 0.6× 18 0.4× 56 448
Catriona Ooi Australia 11 243 1.8× 189 1.4× 64 0.7× 29 0.6× 33 0.8× 45 395
Leila Dal Santo United States 8 149 1.1× 228 1.7× 239 2.8× 85 1.8× 41 1.0× 15 454
Gheorghiță Jugulete Romania 8 128 1.0× 178 1.3× 46 0.5× 23 0.5× 13 0.3× 42 310
Olayinka Olasode Nigeria 11 136 1.0× 129 1.0× 53 0.6× 24 0.5× 17 0.4× 42 340
Aristophane Tanon Ivory Coast 11 267 2.0× 246 1.9× 63 0.7× 17 0.4× 28 0.7× 40 444
Mpho Tlali South Africa 12 189 1.4× 229 1.7× 87 1.0× 26 0.6× 46 1.1× 30 368
Cindy Firnhaber South Africa 12 294 2.2× 238 1.8× 131 1.5× 30 0.7× 84 2.0× 19 515
Tim Bush United States 11 280 2.1× 300 2.3× 79 0.9× 16 0.3× 122 3.0× 19 542

Countries citing papers authored by Feng Cheng

Since Specialization
Citations

This map shows the geographic impact of Feng Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Cheng more than expected).

Fields of papers citing papers by Feng Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Cheng. The network helps show where Feng Cheng may publish in the future.

Co-authorship network of co-authors of Feng Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Cheng. A scholar is included among the top collaborators of Feng Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Cheng. Feng Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Ma, Mei, Mei Zhu, Li Li, et al.. (2020). Use of complete blood count for predicting preterm birth in asymptomatic pregnant women: A propensity score‐matched analysis. Journal of Clinical Laboratory Analysis. 34(8). e23313–e23313. 22 indexed citations
3.
4.
Xu, Junfang, Anders Sönnerborg, Liangmin Gao, et al.. (2020). Delayed Treatment for People Living with HIV in China, 2004–2016: An Analysis of An Observational Cohort. International Journal of Environmental Research and Public Health. 17(5). 1809–1809. 10 indexed citations
5.
Su, Shu, Christopher K. Fairley, Limin Mao, et al.. (2019). Estimates of the national trend of drugs use during 2000–2030 in China: A population-based mathematical model. Addictive Behaviors. 93. 65–71. 15 indexed citations
6.
Ma, Xiaomeng, Qian Wang, Jason J. Ong, et al.. (2018). Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis. Sexually Transmitted Infections. 94(6). 434–442. 53 indexed citations
7.
Ong, Jason J., Xiaomeng Ma, Christopher K. Fairley, et al.. (2018). Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness. Human Vaccines & Immunotherapeutics. 14(12). 3010–3018. 20 indexed citations
8.
Su, Shu, Limin Mao, Chen Liang, et al.. (2018). Epidemics of HIV, HCV and syphilis infection among synthetic drugs only users, heroin-only users and poly-drug users in Southwest China. Scientific Reports. 8(1). 6615–6615. 13 indexed citations
9.
Su, Shu, Lei Zhang, Feng Cheng, et al.. (2018). Association between recreational drug use and sexual practices among people who inject drugs in Southwest China: a cross-sectional study. BMJ Open. 8(6). e019730–e019730. 7 indexed citations
10.
Xu, Junfang, et al.. (2018). Antiretroviral regimen change among people infected with HIV: evidence from a cross-sectional study in China. Global Health Journal. 2(3). 21–30. 1 indexed citations
11.
12.
Su, Shu, Shifu Li, Shunxiang Li, et al.. (2016). Gaps in the Continuum of HIV Care: Long Pretreatment Waiting Time between HIV Diagnosis and Antiretroviral Therapy Initiation Leads to Poor Treatment Adherence and Outcomes. BioMed Research International. 2016. 1–8. 12 indexed citations
13.
Barnett‐Vanes, Ashton, et al.. (2016). Towards an equitable internship programme at WHO: is reform nigh?. BMJ Global Health. 1(2). e000088–e000088. 1 indexed citations
14.
Sabin, Lora, Mary Bachman DeSilva, Christopher Gill, et al.. (2015). Improving Adherence to Antiretroviral Therapy With Triggered Real-time Text Message Reminders. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(5). 551–559. 109 indexed citations
15.
Nelson‐Piercy, C, Joanna Girling, Feng Cheng, et al.. (2006). Dexamethasone in the treatment of obstetric cholestasis: A case series. Journal of Obstetrics and Gynaecology. 26(2). 110–114. 19 indexed citations
16.
Cheng, Feng, et al.. (2001). [Tracing algorithms of ECG tracks from scanned image].. PubMed. 18(2). 306–8, 325. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole C. McCann Breakdown of academic impact, for papers by Hongxin Zhao Breakdown of academic impact, for papers by Catriona Ooi Breakdown of academic impact, for papers by Leila Dal Santo Breakdown of academic impact, for papers by Gheorghiță Jugulete Breakdown of academic impact, for papers by Olayinka Olasode Breakdown of academic impact, for papers by Aristophane Tanon Breakdown of academic impact, for papers by Mpho Tlali Breakdown of academic impact, for papers by Cindy Firnhaber Breakdown of academic impact, for papers by Tim Bush
Rankless by CCL
2026